These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19074985)

  • 1. C-reactive protein and 5-year survival in type 2 diabetes: the Casale Monferrato Study.
    Bruno G; Fornengo P; Novelli G; Panero F; Perotto M; Segre O; Zucco C; Deambrogio P; Bargero G; Perin PC
    Diabetes; 2009 Apr; 58(4):926-33. PubMed ID: 19074985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen and AER are major independent predictors of 11-year cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study.
    Bruno G; Merletti F; Biggeri A; Bargero G; Ferrero S; Pagano G; Cavallo-Perin P;
    Diabetologia; 2005 Mar; 48(3):427-34. PubMed ID: 15696295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal probrain natriuretic peptide is a stronger predictor of cardiovascular mortality than C-reactive protein and albumin excretion rate in elderly patients with type 2 diabetes: the Casale Monferrato population-based study.
    Bruno G; Landi A; Barutta F; Ghezzo G; Baldin C; Spadafora L; Schimmenti A; Prinzis T; Cavallo Perin P; Gruden G
    Diabetes Care; 2013 Sep; 36(9):2677-82. PubMed ID: 23564918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity is associated with lower mortality risk in elderly diabetic subjects: the Casale Monferrato study.
    Perotto M; Panero F; Gruden G; Fornengo P; Lorenzati B; Barutta F; Ghezzo G; Amione C; Cavallo-Perin P; Bruno G
    Acta Diabetol; 2013 Aug; 50(4):563-8. PubMed ID: 22068621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NT-proBNP linking low-moderately impaired renal function and cardiovascular mortality in diabetic patients: the population-based Casale Monferrato Study.
    Bruno G; Barutta F; Landi A; Cavallo Perin P; Gruden G
    PLoS One; 2014; 9(12):e114855. PubMed ID: 25503636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Synergic Association of hs-CRP and Serum Amyloid P Component in Predicting All-Cause Mortality in Patients With Type 2 Diabetes.
    Scarale MG; Copetti M; Garofolo M; Fontana A; Salvemini L; De Cosmo S; Lamacchia O; Penno G; Trischitta V; Menzaghi C
    Diabetes Care; 2020 May; 43(5):1025-1032. PubMed ID: 32144164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uric acid is not an independent predictor of cardiovascular mortality in type 2 diabetes: a population-based study.
    Panero F; Gruden G; Perotto M; Fornengo P; Barutta F; Greco E; Runzo C; Ghezzo G; Cavallo-Perin P; Bruno G
    Atherosclerosis; 2012 Mar; 221(1):183-8. PubMed ID: 22239868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation biomarkers and mortality prediction in patients with type 2 diabetes (ZODIAC-27).
    Landman GW; Kleefstra N; Groenier KH; Bakker SJ; Groeneveld GH; Bilo HJ; van Hateren KJ
    Atherosclerosis; 2016 Jul; 250():46-51. PubMed ID: 27179179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes.
    Sharif S; Van der Graaf Y; Cramer MJ; Kapelle LJ; de Borst GJ; Visseren FLJ; Westerink J;
    Cardiovasc Diabetol; 2021 Nov; 20(1):220. PubMed ID: 34753497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aortic stiffness, inflammation, denutrition and type 2 diabetes in the elderly.
    Blacher J; Protogerou AD; Henry O; Czernichow S; Iaria P; Zhang Y; Agnoletti D; Safar ME
    Diabetes Metab; 2012 Feb; 38(1):68-75. PubMed ID: 22030242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of age on the association of non-high-density-lipoprotein cholesterol and apolipoprotein B with cardiovascular mortality in a Mediterranean population with type 2 diabetes: the Casale Monferrato study.
    Bruno G; Merletti F; Biggeri A; Bargero G; Prina-Cerai S; Pagano G; Cavallo-Perin P
    Diabetologia; 2006 May; 49(5):937-44. PubMed ID: 16525840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study.
    Bruno G; Merletti F; Biggeri A; Bargero G; Ferrero S; Runzo C; Prina Cerai S; Pagano G; Cavallo-Perin P;
    Diabetes Care; 2004 Nov; 27(11):2689-94. PubMed ID: 15505006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein concentration predicts mortality in type 2 diabetes: the Diabetes Heart Study.
    Cox AJ; Agarwal S; M Herrington D; Carr JJ; Freedman BI; Bowden DW
    Diabet Med; 2012 Jun; 29(6):767-70. PubMed ID: 22211818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the clinical usefulness of the metabolic syndrome? The Casale Monferrato study.
    Bruno G; Fornengo P; Segre O; Novelli G; Panero F; Perotto M; Zucco C; Bargero G; Cavallo-Perin P
    J Hypertens; 2009 Dec; 27(12):2403-8. PubMed ID: 19738492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects.
    Juutilainen A; Lehto S; Rönnemaa T; Pyörälä K; Laakso M
    Diabetes Care; 2008 Apr; 31(4):714-9. PubMed ID: 18083789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term impact of HbA1c on morbidity and all-cause mortality in people with type 2 diabetes: a Danish population-based observational study.
    Skriver MV; Støvring H; Kristensen JK; Charles M; Sandbæk A
    Diabetologia; 2012 Sep; 55(9):2361-70. PubMed ID: 22736395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimated glomerular filtration rate, albuminuria and mortality in type 2 diabetes: the Casale Monferrato study.
    Bruno G; Merletti F; Bargero G; Novelli G; Melis D; Soddu A; Perotto M; Pagano G; Cavallo-Perin P
    Diabetologia; 2007 May; 50(5):941-8. PubMed ID: 17333106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Importance of C-Reactive Protein in High Cardiovascular Risk Patients With Type 2 Diabetes Mellitus: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CR; Leite NC; Salles GF
    J Am Heart Assoc; 2016 Oct; 5(11):. PubMed ID: 27912211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between plasma monocyte chemoattractant protein-1 concentration and cardiovascular disease mortality in middle-aged diabetic and nondiabetic individuals.
    Piemonti L; Calori G; Lattuada G; Mercalli A; Ragogna F; Garancini MP; Ruotolo G; Luzi L; Perseghin G
    Diabetes Care; 2009 Nov; 32(11):2105-10. PubMed ID: 19641159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble ST2 is a biomarker for cardiovascular mortality related to abnormal glucose metabolism in high-risk subjects.
    Cardellini M; Rizza S; Casagrande V; Cardolini I; Ballanti M; Davato F; Porzio O; Canale MP; Legramante JM; Mavilio M; Menghini R; Martelli E; Farcomeni A; Federici M
    Acta Diabetol; 2019 Mar; 56(3):273-280. PubMed ID: 30259114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.